Searchable abstracts of presentations at key conferences in endocrinology

ea0016p757 | Thyroid | ECE2008

Thyroglobulin measurement in fine-needle aspirates of cervical lymph nodes in diagnosis of metastic differentiated thyroid cancer

Alfayate Rocio , Lopez Alicia , Martinez-Fuster Sandra , Mauri Montserrat , Moreno-Perez Oscar , Gil Santiago , De la Iglesia Pedro , Cabezas Antonio , Pico Antonio Miguel

Introduction: Serum thyroglobulin (Tg) measurement is the marker of differentiated thyroid carcinoma (DTC) after total thyroidectomy, but its value is limited by the interference of anti-Tg antibodies (TgAb). Detection of Tg in fine-needle aspiration biopsy (TG-FNAB) washout fluid is used recently to identify neck DTC metastases, but the interference of TGAb-FNAB in the procedure is unknown.Objectives: To evaluate the utility of TG-FNAB for detecting cer...

ea0056p130 | Endocrine tumours and neoplasia | ECE2018

Treatment with (177Lu)-dotatate in patients with advanced metastatic somatostatin receptor-positive tumors

Martin-Portugues Antonio Ballesteros , Garcia Maria Isabel del Olmo , Arques Pilar Bello , Huerta Angel Segura , Garcia Juan Antonio Mendez , Torres Juan Francisco Merino

Introduction: The NETTER 1 trial resulted in markedly longer progression-free survival (PFS), with preliminary evidence of an overall survival benefit. We report the results of PFS and safety of (177Lu)-DOTATATE in patients treated in our hospital between 2014 and 2017.Methods: Transversal and descriptive study of 22 patients with advanced, progressive, somatostatin receptor-positive tumors who had received previous treatments. All of them were treated w...

ea0056p499 | Diabetes therapy | ECE2018

Metabolic effects of liraglutide in type 2 diabetic patients.

Muros Mariola Mendez , Portillo Cristobal Morales , Hermosilla Antonio Manuel Garrido , Septimo Vianney Magaly Santiago , Perez Antonio Perez , Margalet Victor Sanchez , Brocca Maria Asuncion Martinez

Objectives: Obesity and type 2 diabetes mellitus (DM2) are risk factors for non-alcoholic fatty liver disease (NAFLD). The main objective was to study the incidence of NAFLD using the Hepatic Steatosis Index (HSI) in obese patients with DM2. Secondary objectives were to analyse the effect of liraglutide over HSI, body mass index (BMI) and glycated hemoglobin (HbA1c).Methods: Retrospective observational study of obese type 2 diabetic patients treated with...

ea0056p785 | Pituitary - Basic | ECE2018

Treatment with antidiabetic biguanide drugs directly impacts the function of multiple pituitary cell types from two non-human primate models

Leon-Gonzalez Antonio J , Vazquez-Borrego Mari C , Fuentes-Fayos Antonio C , Gahete Manuel D , Castano Justo P , Kineman Rhonda D , Luque Raul M

Antidiabetic biguanides, such as metformin (the most commonly prescribed drug to treat type 2 diabetes) and phenformin, are synthetic insulin-sensitizing agents. In addition to their well-known anti-hyperglycemic actions, biguanides are being also studied in other medical disorders due to the beneficial effects that they exert in important pathologies, including cardiovascular disease or different types of cancer. Although some scattered studies have suggested that metformin c...

ea0081oc4.5 | Oral Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Real-world injection experience and use of independent injection among patients using lanreotide autogel/depot (LAN) prefilled syringe or octreotide long-acting release (OCT) to treat acromegaly or neuroendocrine tumors (NETs): international PRESTO 2 survey

Webb Susan , O'Toole Dermot , Kunz Pamela , Houchard Aude , Boiziau Sandra , Ribeiro-Oliveira Antonio , Prebtani Ally

Introduction: Long-acting (LA) somatostatin analog (SSA) therapy is a common first-line medical treatment for acromegaly and NETs. There are limited real-world data on patientsÂ’ injection experience with the latest LA SSA devices/formulations.Aims: To compare the injection experience of patients with acromegaly or NETs who were receiving treatment with LAN prefilled syringe vs OCT syringe.Methods: A 2021 e-survey of adults wit...

ea0081oc11.6 | Oral Communications 11: Thyroid 2 | ECE2022

A new grading system for medullary thyroid cancer

Prete Alessandro , Gambale Carla , Torregrossa Liborio , Bottici Valeria , Cappagli Virginia , Basolo Fulvio , Elisei Rossella , Matrone Antonio

Introduction: medullary thyroid carcinoma (MTC) is a neuroendocrine thyroidal cancer. World Health Organization recognizes a grading system for almost all neuroendocrine tumors; however, a shared grading system for MTC is still lacking. We performed a clinical and pathological review of 257 MTCs to evaluate which histologic features have an impact on the disease specific survival and to propose a new grading system.Method: We retrospectively reviewed cli...

ea0081p181 | Reproductive and Developmental Endocrinology | ECE2022

Hormonal treatment modification during the long term follow-up of transwomen and transmen individuals: a retrospective observational Italian study

Cacciani Marta , Spaggiari Giorgia , M. Granata Antonio R. , Simoni Manuela , Santi Daniele

Background: Persons with assigned either male (AMAB) or female (AFAB) sex at birth might wish to obtain feminization or masculinization, respectively. To this purpose, hormonal treatment with sex hormones must be tailored to each subject. Several studies and the European Society of Endocrinology guidelines tried to identify the optimal hormonal treatment in both AMAB and AFAB subjects. However, the clinical management in the long term follow-up remains challenging. Many treatm...

ea0081p472 | Thyroid | ECE2022

Cervical lymph nodes metastases in differentiated thyroid cancer: impact on clinical outcome

Gambale Carla , Matrone Antonio , Contartese Lea , Prete Alessandro , Viola David , Agate Laura , Molinaro Eleonora , Elisei Rossella

Background: Cervical lymph node metastases at histology are common findings in differentiated thyroid cancer (DTC); however, their impact on clinical outcome is debated.Material and method: 1332 DTC patients, performed the first 131 I treatment between January 2010 and September 2012 and were divided into 2 groups: absence (Nx/N0) or presence (N1) of lymph node metastases at histology. The latter group was further split in central compartment ...

ea0081p473 | Thyroid | ECE2022

Comparison of serum calcitonin and neck ultrasound sensitivities in identifying medullary thyroid carcinoma

Matrone Antonio , Gambale Carla , Prete Alessandro , Cappagli Virginia , Lorusso Loredana , Bottici Valeria , Vitti Paolo , Elisei Rossella

Background: Serum calcitonin (CT) is a very sensitive test for the diagnosis of medullary thyroid carcinoma (MTC). However, its routine dosage in patients with nodular thyroid disease is not recommended by all scientific societies. In addition, to optimize costs, it is only suggested in the case of suspicious nodules on ultrasound, indeterminate nodules at cytology or nodular goiter before surgery. The aim of the study is to evaluate the serum CT in a series of consecutive MTC...

ea0081ep418 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

New-onset diabetes after transplantation (NODAT). A case report

Contreras Pascual Cristina , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Montero Benitez Maria Zhao , Alvarez Lopez Susana

New-onset diabetes after transplantation (NODAT) is a serious complication after a solid organ transplantation. It has been reported to occur in 4% to 25% of renal transplant recipients, 2.5% to 25% of liver transplant recipients, 40% to 60% of hepatitis C virus (HCV) infection and 2% to 53% of all solid organ transplantations. The diagnosis is performed using unmodified criteria for diagnosing diabetes in the general population and risk factors are the commonly recognized fac...